Abstract:In this study, we optimize the alkyl tails of ionizable lipids for LNP‐mediated delivery of three mRNAs of varying sizes in vivo. Different IL tail lengths were found to be ideal for transfection of LNPs encapsulating the three mRNAs tested. We envision that the results of this project can be utilized as future design criteria for the next generation of LNPs. RNA‐based therapeutics have gained traction for the prevention and treatment of a variety of diseases. However, their fragility and immunogenicity necessitate a drug carrier. Lipid nanoparticles (LNPs) have emerged as the predominant delivery vehicle for RNA therapeutics. An important component of LNPs is the ionizable lipid (IL), which is protonated in the acidic environment of the endosome, prompting cargo release into the cytosol. Currently, there is growing evidence that the structure of IL lipid tails significantly impacts the efficacy of LNP‐mediated mRNA translation. Here, we optimized IL tail length for LNP‐mediated delivery of three different mRNA cargos. Using C12‐200, a gold standard IL, as a model, we designed a library of ILs with varying tail lengths and evaluated their potency in vivo. We demonstrated that small changes in lipophilicity can drastically increase or decrease mRNA translation. We identified that LNPs formulated with firefly luciferase mRNA (1929 base pairs) and C10‐200, an IL with shorter tail lengths than C12‐200, enhance liver transfection by over 10‐fold. Furthermore, different IL tail lengths were found to be ideal for transfection of LNPs encapsulating mRNA cargos of varying sizes. LNPs formulated with erythropoietin (EPO), responsible for stimulating red blood cell production, mRNA (858 base pairs), and the C13‐200 IL led to EPO translation at levels similar to the C12‐200 LNP. The LNPs formulated with Cas9 mRNA (4521 base pairs) and the C9‐200 IL induced over three times the quantity of indels compared with the C12‐200 LNP. Our findings suggest that shorter IL tails may lead to higher transfection of LNPs encapsulating larger mRNAs, and that longer IL tails may be more efficacious for delivering smaller mRNA cargos. We envision that the results of this project can be utilized as future design criteria for the next generation of LNP delivery systems for RNA therapeutics.

The transfection potency of lipid nanoparticles containing mRNA depends on relative loading levels

Interaction Kinetics of Individual mRNA-Containing Lipid Nanoparticles with an Endosomal Membrane Mimic: Dependence on pH, Protein Corona Formation, and Lipoprotein Depletion

Role of size, surface charge, and PEGylated lipids of lipid nanoparticles (LNPs) on intramuscular delivery of mRNA

Insights into the formulation of lipid nanoparticles for the optimization of mRNA therapeutics

Optimization of phospholipid chemistry for improved lipid nanoparticle (LNP) delivery of messenger RNA (mRNA).

Optimization of DOTAP/chol Cationic Lipid Nanoparticles for mRNA, pDNA, and Oligonucleotide Delivery

Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles

Tailoring lipid nanoparticle dimensions through manufacturing processes

Mechanistic Studies of an Automated Lipid Nanoparticle Reveal Critical Pharmaceutical Properties Associated with Enhanced mRNA Functional Delivery In Vitro and In Vivo

Elucidation of lipid nanoparticle surface structure in mRNA vaccines

The mixing method used to formulate lipid nanoparticles affects mRNA delivery efficacy and organ tropism

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Influence of ionizable lipid tail length on lipid nanoparticle delivery of mRNA of varying length

Molecular Dynamics Simulation of Lipid Nanoparticles Encapsulating mRNA

Design and lyophilization of mRNA-encapsulating lipid nanoparticles

Evaluating how cationic lipid affects mRNA-LNP physical properties and biodistribution

Influence of lipid composition of messenger RNA-loaded lipid nanoparticles on the protein expression via intratracheal administration in mice

Impact of lipid nanoparticle size on mRNA vaccine immunogenicity

Lipid nanoparticle chemistry determines how nucleoside base modifications alter mRNA delivery

A careful look at lipid nanoparticle characterization: analysis of benchmark formulations for encapsulation of RNA cargo size gradient

A Combinatorial Library of Lipid Nanoparticles for Cell Type‐Specific mRNA Delivery